Literature DB >> 22132880

Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

M Bemark1, J Holmqvist, J Abrahamsson, K Mellgren.   

Abstract

Haematopoietic stem cell transplantation (HSCT) is an immunological treatment that has been used for more than 40 years to cure a variety of diseases. The procedure is associated with serious side effects, due to the severe impairment of the immune system induced by the treatment. After a conditioning regimen with high-dose chemotherapy, sometimes in combination with total body irradiation, haematopoietic stem cells are transferred from a donor, allowing a donor-derived blood system to form. Here, we discuss the current knowledge of humoral problems and B cell development after HSCT, and relate these to the current understanding of human peripheral B cell development. We describe how these studies have aided the identification of subsets of transitional B cells and also a robust memory B cell phenotype.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22132880      PMCID: PMC3248082          DOI: 10.1111/j.1365-2249.2011.04469.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  106 in total

Review 1.  Control systems and decision making for antibody production.

Authors:  Christopher C Goodnow; Carola G Vinuesa; Katrina L Randall; Fabienne Mackay; Robert Brink
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 2.  Human B cell subsets.

Authors:  Stephen M Jackson; Patrick C Wilson; Judith A James; J Donald Capra
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

3.  Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.

Authors:  M Tomblyn; T Chiller; H Einsele; R Gress; K Sepkowitz; J Storek; J R Wingard; J-A H Young; M J Boeckh
Journal:  Bone Marrow Transplant       Date:  2009-10       Impact factor: 5.483

Review 4.  Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins.

Authors:  N Lycke; M Bemark
Journal:  Mucosal Immunol       Date:  2010-09-15       Impact factor: 7.313

5.  Requirements for the adoptive transfer of antibody responses to a priming antigen in man.

Authors:  J Z Wimperis; D Gottlieb; A S Duncombe; H E Heslop; H G Prentice; M K Brenner
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

Review 6.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

7.  T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute graft-versus-host disease.

Authors:  J W Gratama; A Naipal; P Oljans; F E Zwaan; L F Verdonck; T de Witte; J M Vossen; R L Bolhuis; G C de Gast; J Jansen
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

8.  Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.

Authors:  Santi Suryani; David A Fulcher; Brigitte Santner-Nanan; Ralph Nanan; Melanie Wong; Peter J Shaw; John Gibson; Andrew Williams; Stuart G Tangye
Journal:  Blood       Date:  2009-11-17       Impact factor: 22.113

9.  Pneumococcal infections after human bone-marrow transplantation.

Authors:  D J Winston; G Schiffman; D C Wang; S A Feig; C H Lin; E L Marso; W G Ho; L S Young; R P Gale
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

10.  Ig heavy chain third complementarity determining regions (H CDR3s) after stem cell transplantation do not resemble the developing human fetal H CDR3s in size distribution and Ig gene utilization.

Authors:  E Gokmen; F M Raaphorst; D H Boldt; J M Teale
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

View more
  27 in total

Review 1.  Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Authors:  A Vossenkämper; P M K Lutalo; J Spencer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

2.  A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies.

Authors:  Sabine Ivison; Mehrnoush Malek; Rosa V Garcia; Raewyn Broady; Anne Halpin; Manon Richaud; Rollin F Brant; Szu-I Wang; Mathieu Goupil; Qingdong Guan; Peter Ashton; Jason Warren; Amr Rajab; Simon Urschel; Deepali Kumar; Mathias Streitz; Birgit Sawitzki; Stephan Schlickeiser; Janetta J Bijl; Donna A Wall; Jean-Sebastien Delisle; Lori J West; Ryan R Brinkman; Megan K Levings
Journal:  JCI Insight       Date:  2018-12-06

Review 3.  Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.

Authors:  Sophie Servais; Muriel Hannon; Régis Peffault de Latour; Gérard Socie; Yves Beguin
Journal:  Stem Cell Investig       Date:  2017-05-25

4.  CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells.

Authors:  Marc A Schwartz; Nikita S Kolhatkar; Chris Thouvenel; Socheath Khim; David J Rawlings
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

5.  Abnormal phenotypic features of IgM+B cell subsets in patients with chronic hepatitis C virus infection.

Authors:  Fanyun Kong; Bo Feng; Henghui Zhang; Huiying Rao; Jianghua Wang; Xu Cong; Lai Wei
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

Review 6.  Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?

Authors:  U-C Meier; G Giovannoni; J S Tzartos; G Khan
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

7.  Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.

Authors:  Alessia Scarselli; Silvia Di Cesare; Claudia Capponi; Simona Cascioli; Maria L Romiti; Gigliola Di Matteo; Alessandra Simonetti; Paolo Palma; Andrea Finocchi; Barbarella Lucarelli; Rita M Pinto; Ippolita Rana; Giuseppe Palumbo; Maurizio Caniglia; Paolo Rossi; Rita Carsetti; Caterina Cancrini; Alessandro Aiuti
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

8.  Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.

Authors:  David M Burns; Rose Tierney; Claire Shannon-Lowe; Jo Croudace; Charlotte Inman; Ben Abbotts; Sandeep Nagra; Christopher P Fox; Sridhar Chaganti; Charles F Craddock; Paul Moss; Alan B Rickinson; Martin Rowe; Andrew I Bell
Journal:  Blood       Date:  2015-10-08       Impact factor: 25.476

9.  Associations of maternal and infant metabolomes with immune maturation and allergy development at 12 months in the Swedish NICE-cohort.

Authors:  Olle Hartvigsson; Malin Barman; Hardis Rabe; Anna Sandin; Agnes E Wold; Carl Brunius; Ann-Sofie Sandberg
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

Review 10.  B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.

Authors:  Maria J Leandro
Journal:  Arthritis Res Ther       Date:  2013-03-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.